The North America cabergoline tablets market is developing alongside greater attention to endocrine disorders and improved access to specialist diagnosis and treatment. Cabergoline's established role in lowering elevated prolactin levels, combined with the availability of oral formulations and mature healthcare systems, supports regional demand. Ongoing emphasis on appropriate monitoring and...